Weiyan Tang

机构：Jiangsu Cancer Hospital, Nanjing Medical University · ORCID：0000-0002-1023-5001

发表论文 12 篇 · 总被引 279 次 · h-index 7

代表论文

• Therapeutic m 6 A Eraser ALKBH5 mRNA-Loaded Exosome–Liposome Hybrid Nanoparticles Inhibit Progression of Colorectal Cancer in Preclinical Tumor Models (2023 · ACS Nano · 被引 96)
• Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma (2022 · Cancer Letters · 被引 76)
• A new immunotherapy strategy targeted CD30 in peripheral T-cell lymphomas: CAR-modified T-cell therapy based on CD30 mAb (2021 · Cancer Gene Therapy · 被引 27)
• Clinicopathologic and epidemiological characteristics of prognostic factors in post-surgical survival of colorectal cancer patients in Jiangsu Province, China (2019 · Cancer Epidemiology · 被引 25)
• Retrospective study on melanosis coli as risk factor of colorectal neoplasm: a 3-year colonoscopic finding in Zhuhai Hospital, China (2019 · International Journal of Colorectal Disease · 被引 22)
• The FACT-targeted drug CBL0137 enhances the effects of rituximab to inhibit B-cell non-Hodgkin’s lymphoma tumor growth by promoting apoptosis and autophagy (2023 · Cell Communication and Signaling · 被引 19)